[1] 程敬伟,刘文恩,马小军,等.中国成人艰难梭菌感染诊断和治疗专家共识[J].协和医学杂志, 2017, 8(Z1): 131-8.[2] Antonelli M, Martin-Loeches I, Dimopoulos G, et al. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement[J]. Intensive Care Medicine, 2020, 46(2): 215-224.[3] Kunishima H, Ohge H, et al.Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. J Infect Chemother. 2022 May 23:S1341-321[4] Wu KS, Syue LS, Cheng A, et al. Recommendations and guidelines for the treatment of Clostridioides difficile infection in Taiwan[J]. J Microbiol Immunol Infect, 2020, 53(2): 191-208.[5] Kelly CR, Fischer M, Allegretti JR, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections[J]. The American journal of gastroenterology, 2021, 116(6): 1124-47.[6] Poylin V, Hawkins AT, Bhama AR, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection[J]. Diseases of the colon and rectum, 2021, 64(6): 650-68.[7] Johnson S, Lavergne V, Skinner AM, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults[J]. Clin Infect Dis, 2021, 73(5): e1029-44.[8] 中国成人念珠菌病诊断与治疗专家共识[J].中华内科杂志,2020(01):5-17.[9] Furfaro E, Mikulska M, Del Bono V, et al. Bloodstream infections are an improbable cause of positive serum (1, 3)-β-d-glucan in hematology patients[J]. Clinical and Vaccine Immunology, 2014, 21(9): 1357-1359.